medline.ch Respirationstrakt COPD

medline.ch

tellmed.ch

En | De

Impressum | Feedback

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Respirationstrakt » COPD

22. Mai 2012

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Allergische Rhinitis - Pollinosis

Asthma

Bronchitis

COPD

Interstitielle Pneumopathien

Schlaf- Apnoe-Syndrom

Schrift:

Seite 1 von 630


	Artikel 1 - 20 / 12588

	Is hospitalisation for COPD an opportunity for advance care planning? A qualitative study. Prim Care Respir J. Seamark D, Blake S, Seamark C, Hyland ME, Greaves C, Pinnuck M, Ward D, Hawkins A, Halpin D, The East Devon Respiratory Research Group. PMID: 22596245 [PubMed - as supplied by publisher]
	Dyspnea, Chest Wall Hyperinflation, and Rib Cage Distortion in Exercising Patients with Chronic Obstructive Pulmonary Disease. Med Sci Sports Exerc. Bruni GI, Gigliotti F, Binazzi B, Romagnoli I, Duranti R, Scano G. PMID: 22595983 [PubMed - as supplied by publisher]
	A Meta-Analysis on the Impact of Disease-Specific Education Programs on Health Outcomes for Patients with Chronic Obstructive Pulmonary Disease. Geriatr Nurs. Tan JY, Chen JX, Liu XL, Zhang Q, Zhang M, Mei LJ, Lin R. PMID: 22595334 [PubMed - as supplied by publisher]
	Differences between community professional and patient perceptions of chronic obstructive pulmonary disease treatment outcomes: a qualitative study. J Clin Nurs. Cooke M, Thackray S. PMID: 22594385 [PubMed - in process]
	Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. Jeppesen E, Brurberg KG, Vist GE, Wedzicha JA, Wright JJ, Greenstone M, Walters JA. PMID: 22592692 [PubMed - in process]
	Teaching the Use of Respiratory Inhalers to Hospitalized Patients with Asthma or COPD: a Randomized Trial. J Gen Intern Med. Press VG, Arora VM, Shah LM, Lewis SL, Charbeneau J, Naureckas ET, Krishnan JA. PMID: 22592354 [PubMed - as supplied by publisher]
	Sildenafil for COPD: A Randomized Crossover Trial. COPD. Bull T, Badesch DB. PMID: 22587530 [PubMed - in process]
	A Comprehensive Care Management Program to Prevent Chronic Obstructive Pulmonary Disease Hospitalizations: A Randomized, Controlled Trial. Ann Intern Med. Fan VS, Gaziano JM, Lew R, Bourbeau J, Adams SG, Leatherman S, Thwin SS, Huang GD, Robbins R, Sriram PS, Sharafkhaneh A, Mador MJ, Sarosi G, Panos RJ, Rastogi P, Wagner TH, Mazzuca SA, Shannon C, Colling C, Liang MH, Stoller JK, Fiore L, Niewoehner DE. PMID: 22586006 [PubMed - as supplied by publisher]
	Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison. Value Health. Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP. PMID: 22583463 [PubMed - in process]
	Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD. Clin Biochem. Somborac-Ba?ura A, Buljevi? S, Rumora L, Culi? O, Detel D, Pancirov D, Popovi?-Grle S, Varljen J, Cepelak I, Zani?-Grubi?i? T. PMID: 22580392 [PubMed - as supplied by publisher]
	Cognitive dysfunction in patients with chronic obstructive pulmonary disease - A systematic review. Respir Med. Schou L, Ostergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. PMID: 22579108 [PubMed - as supplied by publisher]
	Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther. Wang Y, Lee JY, Michele T, Chowdhury BA, Gobburu JV. PMID: 22578206 [PubMed - as supplied by publisher]
	Mean platelet volume: an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. PMID: 22576316 [PubMed - as supplied by publisher]
	A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice, the CopD Study. J Clin Endocrinol Metab. Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. PMID: 22573406 [PubMed - as supplied by publisher]
	Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, Yoshimura K, Tateishi Y, Arimura Y, Matsumoto N, Yoshikawa M, Yamahara K, Kangawa K. PMID: 22563468 [PubMed - in process]
	Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Int J Chron Obstruct Pulmon Dis. Aisanov Z, Bai C, Bauerle O, Colodenco FD, Feldman C, Hashimoto S, Jardim J, Lai CK, Laniado-Laborin R, Nadeau G, Sayiner A, Shim JJ, Tsai YH, Walters RD, Waterer G. PMID: 22563246 [PubMed - in process]
	Epidemiology of chronic obstructive pulmonary disease: a descriptive study in the mid-western region of Nepal. Int J Chron Obstruct Pulmon Dis. Bhandari R, Sharma R. PMID: 22563245 [PubMed - in process]
	Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study. Int J Chron Obstruct Pulmon Dis. Voduc N, Alvarez GG, Amjadi K, Tessier C, Sabri E, Aaron SD. PMID: 22563244 [PubMed - in process]
	Current best practice in pulmonary rehabilitation for chronic obstructive pulmonary disease. Ther Adv Respir Dis. de Blasio F, Polverino M. PMID: 22563010 [PubMed - as supplied by publisher]
	Early Rehabilitation Exercise Program for Inpatients During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A RANDOMIZED CONTROLLED TRIAL. J Cardiopulm Rehabil Prev. Tang CY, Blackstock FC, Clarence M, Taylor NF. PMID: 22561417 [PubMed - in process]

Artikel 1 - 20 / 12588

Seite 1 von 630



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch Tel: +41 (0)44 204 16 77 Fax: +41(0)44 204 16 70
	Disclaimer \| Privacy Policy